Quote:

---

For the Alzheimer's trial you mentioned that "conditional approval is possible on a phase 2 for that disease so a phase 3 would be unnecessary."

My question is this: Is that also true for the mssCRC trial? Is it possible that conditional approval on a phase 2 for that disease would make a phase 3 unnecessary?

---

Quote:

---

If I remember right, others also mentioned great ORR results can basis Cytodyn filing for early, Conditional Approval.

Quote:

---

In mssCRC with that size of patient population it's highly unlikely.

---

https://investorshangout.com/post/view?id=6727402

---

Besides the patient population size the difference between mssCRC and Alzheimer's is that there is no really viable approved drug for Alzheimer's.